Skip to main content

Table 1 Baseline patient characteristics

From: Quality of recovery in patients administered remimazolam versus those administered an inhalant agent for the maintenance of general anesthesia: a randomized control trial

 

Group R

(n=82)

Group D

(n=83)

Age, y (SD)

43.4 (10.4)

43.2 (9.0)

Male, n (%)

20 (24.4)

18 (21.7)

ASA PS classification, n

 I or II

77

77

 III

5

6

Type of surgery, n

 Laparoscopic cholecystectomy

29

39

 Robotic gynecologic surgery

53

44

Duration of surgery, min

61 (42–95)

60 (41–80)

Duration of anesthesia, min

105 (80–133.8)

100 (82.5–120)

Total dose of rocuronium, mg

50 (40–50)

45 (40–50)

Application of PCA, n (%)

42 (51.2)

38 (45.7)

Reversal of neuromuscular block by sugammadex, n (%)

63 (76.8)

53 (63.8)

  1. ASA PS American Society of Anesthesiologist Physical Status, PCA patient-controlled analgesia, SD standard deviation. Continuous data that were not normally distributed are presented as the median (IQR)